(ONC) BeiGene - Performance 79.3% in 12m
Compare ONC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
25.72%
#24 in Group
Rel. Strength
94.75%
#402 in Universe
Total Return 12m
79.30%
#12 in Group
Total Return 5y
90.48%
#25 in Group
P/E -
(unknown) Percentile in Group
P/E Forward 385
92th Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -2.47%
63th Percentile in Group
12m Total Return: ONC (79.3%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ONC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ONC
| Total Return (including Dividends) | ONC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 11.91% | -5.85% | -3.01% |
| 3 Months | 49.34% | -11.95% | -3.15% |
| 12 Months | 79.30% | -11.00% | 10.19% |
| 5 Years | 90.48% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | ONC | XBI | S&P 500 |
| 1 Month | 60.1% | -59.8% | -5.5% |
| 3 Months | 90.4% | -70.5% | -58.4% |
| 12 Months | 84.1% | -6.9% | 84.1% |
| 5 Years | -39.7% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #23 | 18.9% | 15.4% |
| 3 Month | #9 | 69.6% | 54.2% |
| 12 Month | #13 | 101% | 62.7% |
| 5 Years | #25 | 89.3% | -16.9% |
FAQs
Does ONC BeiGene outperforms the market?
Yes,
over the last 12 months ONC made 79.30%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ONC made 49.34%, while XBI made -11.95%.
Over the last 3 months ONC made 49.34%, while XBI made -11.95%.
Performance Comparison ONC vs Indeces and Sectors
ONC vs. Indices ONC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 10.2% | 14.9% | 17.8% | 69.1% |
| US NASDAQ 100 | QQQ | 11.2% | 16.0% | 18.5% | 70.7% |
| US Dow Jones Industrial 30 | DIA | 10.0% | 14.1% | 16.8% | 69.8% |
| German DAX 40 | DAX | 11.5% | 15.3% | 0.97% | 57.6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 10.5% | 11.7% | 33.0% | 70.2% |
| Hongkong Hang Seng | HSI | 8.26% | 9.14% | 27.0% | 62.0% |
| India NIFTY 50 | INDA | 9.20% | 4.04% | 28.1% | 78.6% |
| Brasil Bovespa | EWZ | 10.1% | 3.62% | 25.8% | 91.0% |
ONC vs. Sectors ONC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 11.8% | 15.7% | 9.65% | 60.1% |
| Consumer Discretionary | XLY | 9.47% | 15.7% | 14.4% | 65.2% |
| Consumer Staples | XLP | 7.44% | 13.8% | 16.9% | 68.3% |
| Energy | XLE | 9.14% | 3.89% | 12.2% | 78.5% |
| Financial | XLF | 9.75% | 14.6% | 5.60% | 57.1% |
| Health Care | XLV | 9.81% | 15.1% | 22.5% | 77.6% |
| Industrial | XLI | 9.92% | 12.6% | 18.5% | 70.8% |
| Materials | XLB | 9.13% | 11.4% | 25.9% | 83.2% |
| Real Estate | XLRE | 8.19% | 14.6% | 20.9% | 65.9% |
| Technology | XLK | 11.4% | 15.9% | 22.9% | 77.3% |
| Utilities | XLU | 6.94% | 11.1% | 18.6% | 54.1% |
| Aerospace & Defense | XAR | 10.8% | 10.6% | 13.8% | 58.4% |
| Biotech | XBI | 14.8% | 17.8% | 35.5% | 90.3% |
| Homebuilder | XHB | 9.73% | 11.8% | 37.1% | 87.0% |
| Retail | XRT | 7.93% | 12.4% | 21.8% | 84.1% |